507 results on '"Blanco, Julià"'
Search Results
2. Immunisation efficacy of a stabilised SARS-CoV-2 spike glycoprotein in two geriatric animal models
3. A monoclonal antibody targeting a large surface of the receptor binding motif shows pan-neutralizing SARS-CoV-2 activity
4. Virus-like particle-mediated delivery of structure-selected neoantigens demonstrates immunogenicity and antitumoral activity in mice
5. Production and characterization of novel Anti-HIV Fc-fusion proteins in plant-based systems: Nicotiana benthamiana & tobacco BY-2 cell suspension
6. Safety and immunogenicity of a recombinant protein RBD fusion heterodimer vaccine against SARS-CoV-2
7. An engineered HIV-1 Gag-based VLP displaying high antigen density induces strong antibody-dependent functional immune responses
8. Alanine-based spacers promote an efficient antigen processing and presentation in neoantigen polypeptide vaccines
9. VLPs generated by the fusion of RSV-F or hMPV-F glycoprotein to HIV-Gag show improved immunogenicity and neutralizing response in mice
10. Efficacy and safety of mRNA1273 SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Single center experience
11. β-Cyclodextrins as affordable antivirals to treat coronavirus infection
12. Preclinical evaluation of PHH-1V vaccine candidate against SARS-CoV-2 in non-human primates
13. Macrophage CD5L is a target for cancer immunotherapy
14. Impact of hybrid immunity booster vaccination and Omicron breakthrough infection on SARS-CoV-2 VOCs cross-neutralization
15. Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2
16. Kinetics of immune responses elicited after three mRNA COVID-19 vaccine doses in predominantly antibody-deficient individuals
17. Epidemiology and resource use in Spanish type 2 diabetes patients without previous cardiorenal disease: CaReMe Spain study summary
18. Physicochemical characterization of the recombinant lectin scytovirin and microbicidal activity of the SD1 domain produced in rice against HIV-1
19. Glucocorticoids’ treatment impairs the medium-term immunogenic response to SARS-CoV-2 mRNA vaccines in Systemic Lupus Erythematosus patients
20. Biomarker candidates for progression and clinical management of COVID-19 associated pneumonia at time of admission
21. High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial
22. Clinical course impacts early kinetics,magnitude, and amplitude of SARS-CoV-2 neutralizing antibodies beyond 1 year after infection
23. Detection of SARS-CoV-2 in a cat owned by a COVID-19–affected patient in Spain
24. SARS-CoV-2 interaction with Siglec-1 mediates trans-infection by dendritic cells
25. Omicron XBB.1.16-Adapted Vaccine for COVID-19: Interim Immunogenicity and Safety Clinical Trial Results.
26. Production and Immunogenicity of FeLV Gag-Based VLPs Exposing a Stabilized FeLV Envelope Glycoprotein.
27. Author Correction to: SARS-CoV-2 interaction with Siglec-1 mediates trans-infection by dendritic cells
28. Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronaviruses
29. SARS-CoV-2 infection elicits a rapid neutralizing antibody response that correlates with disease severity
30. Carbon footprint of tourism in Barcelona
31. New emerging targets in cancer immunotherapy: the role of neoantigens
32. Nucleic Acid Vaccines Encoding Proteins and Virus-like Particles for HIV Prevention.
33. Influence of the ARV regimen on the early changes in plasma HIV RNA and immune activation at initiation of antiretroviral therapy in naïve HIV-1–infected patients
34. 3145 – NSGS MICE HUMANIZED WITH CORD BLOOD CD34NEG MONONUCLEAR CELLS SHOW SUSTAINED AND FUNCTIONAL MYELOID-LYMPHOID REPRESENTATION WITH LIMITED GRAFT-VERSUS-HOST-DISEASE
35. Production of HIV-1-based virus-like particles for vaccination: achievements and limits
36. Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection
37. Influence of the Antiretroviral Regimen on the Early Changes in Plasma HIV RNA and Immune Activation at Initiation of Antiretroviral Therapy in Naïve HIV-1–Infected Patients
38. Interferon-γ–Inducible Protein 10 (IP-10) as a Screening Tool to Optimize Human Immunodeficiency Virus RNA Monitoring in Resource-Limited Settings
39. New signatures of poor CD4 cell recovery after suppressive antiretroviral therapy in HIV-1-infected individuals: involvement of miR-192, IL-6, sCD14 and miR-144
40. Life cycle assessment of flexibly fed biogas processes for an improved demand-oriented biogas supply
41. Short-term Treatment With Interferon Alfa Diminishes Expression of HIV-1 and Reduces CD4 + T-Cell Activation in Patients Coinfected With HIV and Hepatitis C Virus and Receiving Antiretroviral Therapy
42. Evolution of the gut microbiome following acute HIV-1 infection
43. HIV-1 envelope glycoproteins isolated from Viremic Non-Progressor individuals are fully functional and cytopathic
44. Demonstration of Antibodies Against SARS-CoV-2, Neutralizing or Binding, in Seroconversion Panels After mRNA-1273, BNT-162b2, and Ad26.COV2.S Vaccine Administration.
45. Mitochondrial haplogroup H is related to CD4+ T cell recovery in HIV infected patients starting combination antiretroviral therapy
46. Enhancing the practical implementation of life cycle sustainability assessment – proposal of a Tiered approach
47. Cyanovirin-N binds to select SARS-CoV-2 spike oligosaccharides outside of the receptor binding domain and blocks infection by SARS-CoV-2
48. Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidate
49. Application challenges for the social Life Cycle Assessment of fertilizers within life cycle sustainability assessment
50. Multifunctionality-solving approaches of compost application in crop rotations
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.